Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. A key breakthrough area where big data analytics has shown tremendous scope and application is in systems biology, which has […]

Torx Software and CAS, a division of the American Chemical Society, have revealed that they will collbaorate to connect CAS SciFinder users through the Torx platform to streamline workflows for discovery chemistry.   CAS SciFinder is designed to provide solutions to challenges encountered in scientific research and discovery, across multiple stages of research and development, including […]

Find out what’s new in the world of tools and services for the drug discovery industry with our update below.  CFX Opus Deepwell Dx Real-Time PCR System – Bio-Rad Laboratories  Bio-Rad Laboratories has launched the CFX Opus Deepwell Dx Real-Time PCR System, which offers accurate and precise quantification with flexibility for reactions up to 125 […]

On February 17 at 8am PST / 11am EST / 4pm GMT / 5pm CET, join DDW to enjoy this free webinar, Cell and gene therapy: sustaining growth and maximising opportunities. Cell and gene therapies (CGT) are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will […]

Mesoblast has resubmitted its biologics license application (BLA) to the US Food and Drug Administration (FDA) for approval of remestemcel-L in the treatment of children with steroid-refractory acute graft versus host disease (SR-aGVHD).  Survival outcomes have not improved over the past two decades for the most severe forms of SR- aGVHD, a life-threatening complication of […]

News round-up for 30 January – 3 February by DDW Digital Content Editor Diana Spencer.  As February 4 is World Cancer Day, this week’s update focuses on developments in the field of oncology. Drugs for lung cancer, lymphoma and breast cancer have received regulatory approvals, an investment boost will allow the development of a novel approach to treating tumours, and […]

Researchers have found a range of commonly prescribed antidepressants can increase bacteria’s resistance to antibiotic medications. A study led by Professor Jianhua Guo from University of Queensland’s Australian Centre for Water and Environmental Biotechnology focused on prescription drugs used to treat depressive disorders, anxiety disorders, and other psychological conditions.  More than 42 million prescriptions were […]

A research group from the National Institutes of Health has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.   SUDV, identified in 1976, is one of the four viruses known to cause human Ebolavirus disease. The new vaccine, VSV-SUDV, completely protected cynomolgus macaques against a lethal SUDV challenge. […]

The US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat) for the once-a-day treatment of anaemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.   Jesduvroq is the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) approved in the US.  Tony Wood, President and Chief […]

A major boost of £1.76 million ($2.16 million) will fund research designed to stop antibiotics failing, to help mitigate the rising threat of antibiotic resistance.  Professor Stefano Pagliara, at the University of Exeter, has received the award to advance his work on controlling the processes and biological mechanisms that cause antibiotics to fail, and can […]